The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Computational Medicine and Drug Designing Software-Global Market Insights and Sales Trends 2025
Synopsis
The global Computational Medicine and Drug Designing Software market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Computational Medicine and Drug Designing Software in various end use industries. The expanding demands from the Drug Discovery and Development, Computational Physiological Medicine, Disease Modeling and Medical Imaging, are propelling Computational Medicine and Drug Designing Software market. Cloud-based, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the On-premise segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Computational Medicine and Drug Designing Software, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Computational Medicine and Drug Designing Software market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Computational Medicine and Drug Designing Software market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Computational Medicine and Drug Designing Software sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Computational Medicine and Drug Designing Software covered in this report include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, etc.
The global Computational Medicine and Drug Designing Software market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Global Computational Medicine and Drug Designing Software market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Computational Medicine and Drug Designing Software market, Segment by Type:
Cloud-based
On-premise
Global Computational Medicine and Drug Designing Software market, by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Computational Medicine and Drug Designing Software companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Computational Medicine and Drug Designing Software market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Computational Medicine and Drug Designing Software in various end use industries. The expanding demands from the Drug Discovery and Development, Computational Physiological Medicine, Disease Modeling and Medical Imaging, are propelling Computational Medicine and Drug Designing Software market. Cloud-based, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the On-premise segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Computational Medicine and Drug Designing Software, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Computational Medicine and Drug Designing Software market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Computational Medicine and Drug Designing Software market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Computational Medicine and Drug Designing Software sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Computational Medicine and Drug Designing Software covered in this report include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, etc.
The global Computational Medicine and Drug Designing Software market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Global Computational Medicine and Drug Designing Software market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Computational Medicine and Drug Designing Software market, Segment by Type:
Cloud-based
On-premise
Global Computational Medicine and Drug Designing Software market, by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Computational Medicine and Drug Designing Software companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Computational Medicine and Drug Designing Software
1.1 Computational Medicine and Drug Designing Software Market Overview
1.1.1 Computational Medicine and Drug Designing Software Product Scope
1.1.2 Computational Medicine and Drug Designing Software Market Status and Outlook
1.2 Global Computational Medicine and Drug Designing Software Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Computational Medicine and Drug Designing Software Market Size by Region (2018-2029)
1.4 Global Computational Medicine and Drug Designing Software Historic Market Size by Region (2018-2023)
1.5 Global Computational Medicine and Drug Designing Software Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Computational Medicine and Drug Designing Software Market Size (2018-2029)
1.6.1 North America Computational Medicine and Drug Designing Software Market Size (2018-2029)
1.6.2 Europe Computational Medicine and Drug Designing Software Market Size (2018-2029)
1.6.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Size (2018-2029)
1.6.4 Latin America Computational Medicine and Drug Designing Software Market Size (2018-2029)
1.6.5 Middle East & Africa Computational Medicine and Drug Designing Software Market Size (2018-2029)
2 Computational Medicine and Drug Designing Software Market by Type
2.1 Introduction
2.1.1 Cloud-based
2.1.2 On-premise
2.2 Global Computational Medicine and Drug Designing Software Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2018-2023)
2.2.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Computational Medicine and Drug Designing Software Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Computational Medicine and Drug Designing Software Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Computational Medicine and Drug Designing Software Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Computational Medicine and Drug Designing Software Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Computational Medicine and Drug Designing Software Revenue Breakdown by Type (2018-2029)
3 Computational Medicine and Drug Designing Software Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery and Development
3.1.2 Computational Physiological Medicine
3.1.3 Disease Modeling
3.1.4 Medical Imaging
3.1.5 Predictive Analysis of Drug Targets
3.2 Global Computational Medicine and Drug Designing Software Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2018-2023)
3.2.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Computational Medicine and Drug Designing Software Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Computational Medicine and Drug Designing Software Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Computational Medicine and Drug Designing Software Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Computational Medicine and Drug Designing Software Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Computational Medicine and Drug Designing Software Revenue Breakdown by Application (2018-2029)
4 Computational Medicine and Drug Designing Software Competition Analysis by Players
4.1 Global Computational Medicine and Drug Designing Software Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Computational Medicine and Drug Designing Software as of 2022)
4.3 Date of Key Players Enter into Computational Medicine and Drug Designing Software Market
4.4 Global Top Players Computational Medicine and Drug Designing Software Headquarters and Area Served
4.5 Key Players Computational Medicine and Drug Designing Software Product Solution and Service
4.6 Competitive Status
4.6.1 Computational Medicine and Drug Designing Software Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Entelos
5.1.1 Entelos Profile
5.1.2 Entelos Main Business
5.1.3 Entelos Computational Medicine and Drug Designing Software Products, Services and Solutions
5.1.4 Entelos Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.1.5 Entelos Recent Developments
5.2 Crown Bioscience
5.2.1 Crown Bioscience Profile
5.2.2 Crown Bioscience Main Business
5.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Products, Services and Solutions
5.2.4 Crown Bioscience Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.2.5 Crown Bioscience Recent Developments
5.3 Chemical Computing Group
5.3.1 Chemical Computing Group Profile
5.3.2 Chemical Computing Group Main Business
5.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Products, Services and Solutions
5.3.4 Chemical Computing Group Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.3.5 Nimbus Therapeutics Recent Developments
5.4 Nimbus Therapeutics
5.4.1 Nimbus Therapeutics Profile
5.4.2 Nimbus Therapeutics Main Business
5.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Products, Services and Solutions
5.4.4 Nimbus Therapeutics Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.4.5 Nimbus Therapeutics Recent Developments
5.5 Schrodinger
5.5.1 Schrodinger Profile
5.5.2 Schrodinger Main Business
5.5.3 Schrodinger Computational Medicine and Drug Designing Software Products, Services and Solutions
5.5.4 Schrodinger Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.5.5 Schrodinger Recent Developments
5.6 Dassault Systemes
5.6.1 Dassault Systemes Profile
5.6.2 Dassault Systemes Main Business
5.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Products, Services and Solutions
5.6.4 Dassault Systemes Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.6.5 Dassault Systemes Recent Developments
5.7 Genedata
5.7.1 Genedata Profile
5.7.2 Genedata Main Business
5.7.3 Genedata Computational Medicine and Drug Designing Software Products, Services and Solutions
5.7.4 Genedata Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.7.5 Genedata Recent Developments
5.8 Biognos
5.8.1 Biognos Profile
5.8.2 Biognos Main Business
5.8.3 Biognos Computational Medicine and Drug Designing Software Products, Services and Solutions
5.8.4 Biognos Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.8.5 Biognos Recent Developments
5.9 Leadscope
5.9.1 Leadscope Profile
5.9.2 Leadscope Main Business
5.9.3 Leadscope Computational Medicine and Drug Designing Software Products, Services and Solutions
5.9.4 Leadscope Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.9.5 Leadscope Recent Developments
5.10 Rhenovia Pharma Limited
5.10.1 Rhenovia Pharma Limited Profile
5.10.2 Rhenovia Pharma Limited Main Business
5.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Products, Services and Solutions
5.10.4 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.10.5 Rhenovia Pharma Limited Recent Developments
5.11 Compugen
5.11.1 Compugen Profile
5.11.2 Compugen Main Business
5.11.3 Compugen Computational Medicine and Drug Designing Software Products, Services and Solutions
5.11.4 Compugen Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.11.5 Compugen Recent Developments
5.12 Certara LP
5.12.1 Certara LP Profile
5.12.2 Certara LP Main Business
5.12.3 Certara LP Computational Medicine and Drug Designing Software Products, Services and Solutions
5.12.4 Certara LP Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.12.5 Certara LP Recent Developments
5.13 Prosarix
5.13.1 Prosarix Profile
5.13.2 Prosarix Main Business
5.13.3 Prosarix Computational Medicine and Drug Designing Software Products, Services and Solutions
5.13.4 Prosarix Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.13.5 Prosarix Recent Developments
5.14 Simulations Plus
5.14.1 Simulations Plus Profile
5.14.2 Simulations Plus Main Business
5.14.3 Simulations Plus Computational Medicine and Drug Designing Software Products, Services and Solutions
5.14.4 Simulations Plus Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.14.5 Simulations Plus Recent Developments
5.15 Strand Life Sciences
5.15.1 Strand Life Sciences Profile
5.15.2 Strand Life Sciences Main Business
5.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Products, Services and Solutions
5.15.4 Strand Life Sciences Computational Medicine and Drug Designing Software Revenue (US$ Million) & (2018-2023)
5.15.5 Strand Life Sciences Recent Developments
6 North America
6.1 North America Computational Medicine and Drug Designing Software Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Computational Medicine and Drug Designing Software Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Computational Medicine and Drug Designing Software Market Dynamics
11.1 Computational Medicine and Drug Designing Software Industry Trends
11.2 Computational Medicine and Drug Designing Software Market Drivers
11.3 Computational Medicine and Drug Designing Software Market Challenges
11.4 Computational Medicine and Drug Designing Software Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
